Nivolumab (anti-PD-1; BMS-936558, ONO-4538) and ipilimumab in first-line NSCLC: Interim phase I results Meeting Abstract
| Authors: | Antonia, S. J.; Gettinger, S. N.; Chow, L. Q. M.; Juergens, R. A.; Borghaei, H.; Shen, Y.; Harbison, C.; Chen, A. C.; Ready, N.; Rizvi, N. A. |
| Abstract Title: | Nivolumab (anti-PD-1; BMS-936558, ONO-4538) and ipilimumab in first-line NSCLC: Interim phase I results |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204088 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.8023 |
| Notes: | Meeting Abstract: 8023 -- 50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL -- S -- Source: Wos |
